A prospective real-world analysis of erenumab in refractory chronic migraine

A prospective real-world analysis of erenumab in refractory chronic migraine

Abstract Background Clinical trials have shown the safety and clinical superiority of erenumab compared to placebo in chronic migraine (CM). The aim of this analysis is to evaluate the effectiveness and tolerability of erenumab in a real-world setting in patients with refractory CM. Methods This is...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Giorgio Lambru, Bethany Hill, Madeleine Murphy, Ivona Tylova, Anna P. Andreou
פורמט: Article
שפה:English
יצא לאור: BMC 2020-06-01
סדרה:The Journal of Headache and Pain
נושאים:
Erenumab
Chronic migraine
Refractory migraine
CGRP
Monoclonal antibodies
גישה מקוונת:http://link.springer.com/article/10.1186/s10194-020-01127-0

אינטרנט

http://link.springer.com/article/10.1186/s10194-020-01127-0

פריטים דומים